ResearcherHubei University of TechnologyActive in the last 2 years

Hao Lyu

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-1634-601X; OpenAlex author ID A5013898529. Sources: OpenAlex.

Their work

Papers: 7 (first author 1, last author 0)
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 9

Papers, trials and grants by year

2023: 1 paper · 2024: 2 papers · 2025: 1 paper · 2026: 3 papers

Papers 7

Phosphorylated STYK1 Promotes Gemcitabine Resistance via Autophagy-Mediated Cancer Stemness in Pancreatic Cancer. Co-author DOI 10.1002/advs.202521488 ↗
tRNA m2G methyltransferase complex THUMPD3-TRMT112 promotes pancreatic cancer progression and autophagy via modulating TFEB translation. Co-author DOI 10.1186/s12943-025-02540-2 ↗
Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. First author DOI 10.3390/biology15070574 ↗
Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer. Co-author DOI 10.1016/j.jare.2025.02.001 ↗
The Emerging Scenario of Ferroptosis in Pancreatic Cancer Tumorigenesis and Treatment. Co-author DOI 10.3390/ijms252413334 ↗
LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. Co-author DOI 10.7150/ijbs.91832 ↗
Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Adenocarcinoma. Co-author DOI 10.3390/biology12020319 ↗

Closest collaborators

The 9 strongest of 9 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jingfeng Tang · 7 shared papers, 2023–2026 · strength 1.61
Cefan Zhou · 7 shared papers, 2023–2026 · strength 1.61
Rui Zhang · 2 shared papers, 2023–2024 · strength 0.41
- Paper LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. DOI 10.7150/ijbs.91832 ↗
- Paper Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Ad… DOI 10.3390/biology12020319 ↗
Xiaowen Li · 1 shared paper, 2026 · strength 0.27
- Paper Decoding Drug Resistance in Pancreatic Cancer: A Subcellular Structure Perspective. DOI 10.3390/biology15070574 ↗
Mengmeng Shi · 1 shared paper, 2025 · strength 0.26
- Paper Long non-coding RNAs: Emerging regulators of invasion and metastasis in pancreatic cancer. DOI 10.1016/j.jare.2025.02.001 ↗
Wenbin Yuan · 1 shared paper, 2026 · strength 0.24
- Paper tRNA m2G methyltransferase complex THUMPD3-TRMT112 promotes pancreatic cancer progression and autophagy via modulating … DOI 10.1186/s12943-025-02540-2 ↗
Yu-Han Huang · 1 shared paper, 2024 · strength 0.23
- Paper LncRNAs as nodes for the cross-talk between autophagy and Wnt signaling in pancreatic cancer drug resistance. DOI 10.7150/ijbs.91832 ↗
Xueying Dong · 1 shared paper, 2026 · strength 0.22
- Paper Phosphorylated STYK1 Promotes Gemcitabine Resistance via Autophagy-Mediated Cancer Stemness in Pancreatic Cancer. DOI 10.1002/advs.202521488 ↗
Yuan Huang · 1 shared paper, 2023 · strength 0.18
- Paper Identification of Wnt/β-Catenin- and Autophagy-Related lncRNA Signature for Predicting Immune Efficacy in Pancreatic Ad… DOI 10.3390/biology12020319 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.